Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic Shock
Comparison of the Accuracy of Monitoring Devices in Prediction of Fluid Responsiveness in Severe Sepsis and Septic Shock
1 other identifier
interventional
38
1 country
1
Brief Summary
Comparison of noninvasive cardiac output monitor (NICOM, Cheetah Medical) with Edwards FloTrac minimally-invasive cardiac output monitor in predicting fluid responsiveness in sepsis and septic shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 30, 2016
CompletedFirst Posted
Study publicly available on registry
November 23, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2022
CompletedJuly 2, 2021
June 1, 2021
3.1 years
October 30, 2016
June 30, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Number of participants who have agreement or disagreement between passive leg raise response and subsequent intravenous fluid challenge
Positive passive leg raise response is defined as a 10% or greater increase in any of: stroke volume index, cardiac index, or pulse pressure following passive leg raise of 45 degrees for 3 minutes. Positive response to fluid challenge is defined as a 10% or greater increase in any of the same parameters following a 500ml or 1000 ml fluid challenge given over 10-15 minutes, using the same instrument, (NICOM or FloTrac). A negative response would be \< 10% increase in these parameters using the same instrument
15 minutes
Secondary Outcomes (1)
Decrease in vasopressor dose, in response to fluid therapy guided by passive leg raise response using NICOM or Flotrac devices
48 hours
Study Arms (1)
NICOM/FloTrac
EXPERIMENTAL500-1000ml Crystalloid fluid challenge (normal saline or plasmalyte) to be given for positive passive leg raise test by either device, and also will be given at baseline, regardless of baseline PLR response.
Interventions
Use of noninvasive cardiac output and minimally invasive cardiac output monitors
500-1000ml Normal Saline or Plasmalyte intravenous fluid bolus will be given at baseline, and following a positive passive leg raise response as defined by a 10% or greater increase in any of: stroke volume index, cardiac index, or pulse pressure, as measured by the NICOM or FloTrac Monitors.
Eligibility Criteria
You may qualify if:
- All adult patients with severe sepsis or septic shock, who have arterial catheter placed with FloTrac monitor, with or without a central venous catheter.
You may not qualify if:
- Declination of consent
- Known allergy to adhesive
- Pregnancy
- Contraindication to raising legs or head to 45 degrees for 3 minute intervals
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Santa Barbara Cottage Hospital
Santa Barbara, California, 93105, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 30, 2016
First Posted
November 23, 2016
Study Start
May 1, 2015
Primary Completion
June 1, 2018
Study Completion
May 1, 2022
Last Updated
July 2, 2021
Record last verified: 2021-06
Data Sharing
- IPD Sharing
- Will not share